Covid-19 live updates: Latest news and analysis
Experts urge caution at Labor Day celebrations after cases spiked following other U.S. holidays. Melbourne, Australia, extended its lockdown by two weeks.
Health Care, Local News, News Now!
Category: Health Care
How are you feeling today? Keep up to date on news and stories related to health care here!
Business, Health Care, News Now!
The national debt is astronomical: Look to the cosmos to put it in perspective
Coronavirus is the culprit. — Chad Pergram
Health Care, News Now!
Covid-19 News: Live Updates
That message ran counter to the optimistic assertions in recent days from the White House.
Health Care, News Now!
Covid-19 News: Live Updates
U.S. colleges are cracking down on parties as campus infections rise. South Korea’s much vaunted strategy for battling the virus is under pressure as a second wave of cases sweeps the country.
Health Care
Legend Biotech reports second quarter 2020 financial results
SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today reported financial results for the quarter ended June 30, 2020. “Legend Biotech
Business, Health Care
Topcon announces the U.S. launch of Aladdin-M
Company Introduces Tool for Measuring and Monitoring Axial Length Metrics OAKLAND, N.J.–(BUSINESS WIRE)–#SeeingEyeHealthDifferently–Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched its new Aladdin-M instrument to the US
Business, Health Care
Dr. Reddy’s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. market
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Penicillamine Capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine®
Business, Health Care
Bristol Myers Squibb provides update on Phase 3 IDHENTIFY trial in patients with relapsed or refractory acute myeloid leukemia
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #AML—Bristol Myers Squibb (NYSE:BMY) today announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus best supportive care (BSC) versus conventional care regimens, which include best supportive care (BSC) only, azacitidine plus BSC, low-dose cytarabine plus BSC or
Health Care
Merck’s KEYTRUDA® (pembrolizumab) receives two new approvals in Japan
KEYTRUDA Now Approved for Patients With PD-L1-Positive Esophageal Squamous Cell Carcinoma Who Have Progressed After Chemotherapy and for a Six-Week Dosing Schedule Across All Adult Indications Six-Week Dosing Schedule for KEYTRUDA Now Approved in Japan, US and Europe KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck